{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 37
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20140911",
          "submission_class_code": "N/A",
          "submission_class_code_description": "Not Applicable",
          "application_docs": [
            {
              "id": "40102",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202053Orig1s000lbl.pdf",
              "date": "20140923",
              "type": "Label"
            },
            {
              "id": "9947",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202053Orig1s000ltr.pdf",
              "date": "20140916",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20240220",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        }
      ],
      "application_number": "ANDA202053",
      "sponsor_name": "REGCON HOLDINGS",
      "openfda": {
        "application_number": [
          "ANDA202053"
        ],
        "brand_name": [
          "DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC",
          "DORZOLAMIDE HYDROCHLORIDE"
        ],
        "generic_name": [
          "DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC",
          "DORZOLAMIDE"
        ],
        "manufacturer_name": [
          "Florida Pharmaceutical Products, LLC",
          "Indoco Remedies Limited"
        ],
        "product_ndc": [
          "71921-400",
          "14445-404"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "OPHTHALMIC"
        ],
        "substance_name": [
          "DORZOLAMIDE HYDROCHLORIDE"
        ],
        "rxcui": [
          "310015"
        ],
        "spl_id": [
          "dfe4a7f4-7ff1-4095-94e1-ef69a1ebe4a3",
          "746e0cc7-7ea7-4090-acb3-69de5fe85be3"
        ],
        "spl_set_id": [
          "e4e6a5a8-f7be-4424-83f2-d6bb4d57443e",
          "462a61b2-1ec6-4d18-bc6b-fc03e027caa0"
        ],
        "package_ndc": [
          "71921-400-10",
          "14445-404-10"
        ],
        "unii": [
          "QZO5366EW7"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "DORZOLAMIDE HYDROCHLORIDE",
          "active_ingredients": [
            {
              "name": "DORZOLAMIDE HYDROCHLORIDE",
              "strength": "EQ 2% BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "SOLUTION/DROPS",
          "route": "OPHTHALMIC",
          "marketing_status": "Prescription",
          "te_code": "AT"
        }
      ]
    }
  ]
}